Dose Escalation in the Ketamine Literature: What Studies Describe

How escalation is described in the literature

The following describes patterns reported in published studies and clinic practice surveys. It is a description of what researchers have observed, not guidance for any individual.

• Studies typically define a fixed induction dose set by the protocol.
• Where response is reported as partial, some practice surveys describe clinicians making upward adjustments.
• Dose-finding research compares a defined range of study doses rather than recommending any single one.
• Where no response emerges, published practice patterns describe changing modality, adding psychotherapy, or stopping treatment.

Why the literature cautions against assuming more is better

• Cardiovascular load: Blood pressure and heart rate rise dose-dependently.
• Dissociation: Reported intensity increases with dose and can become destabilizing.
• Nausea and vomiting: Reported more frequently at higher study doses.
• Tolerance: Frequent higher-dose exposure may accelerate neuroadaptation.

Monitoring described in higher-dose research

Studies using higher doses describe closer vitals monitoring, secured vascular access, and anti-nausea premedication. Readers who want to understand a clinic's monitoring practices can raise the question directly with that clinic.

Modality change as an alternative in the literature

Because the reported dose-response relationship flattens, published discussions note that further escalation is not the only option considered when response stalls. Alternatives described include adding psychotherapy, intramuscular administration (a different pharmacokinetic profile), or intranasal esketamine, which carries its own FDA-approved labeling.

De-escalation in published practice patterns

Once response is established, practice reports describe clinicians reducing dose during maintenance to find a minimum effective level. Whether and how that applies to any person is a clinical judgment.